Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 2
1977 2
1978 2
1980 1
1981 2
1982 3
1983 3
1984 3
1985 3
1986 3
1987 4
1988 11
1989 7
1990 7
1991 4
1992 7
1993 8
1994 10
1995 3
1996 8
1997 18
1998 9
1999 10
2000 19
2001 14
2002 12
2003 12
2004 10
2005 17
2006 18
2007 25
2008 24
2009 21
2010 22
2011 22
2012 43
2013 32
2014 37
2015 42
2016 40
2017 45
2018 55
2019 58
2020 54
2021 63
2022 72
2023 52
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

881 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Combined and Alone Transcranial Motor Cortex Stimulation and Mirror Therapy in Phantom Limb Pain: A Randomized Factorial Trial.
Gunduz ME, Pacheco-Barrios K, Bonin Pinto C, Duarte D, Vélez FGS, Gianlorenco ACL, Teixeira PEP, Giannoni-Luza S, Crandell D, Battistella LR, Simis M, Fregni F. Gunduz ME, et al. Among authors: velez fgs. Neurorehabil Neural Repair. 2021 Aug;35(8):704-716. doi: 10.1177/15459683211017509. Epub 2021 Jun 1. Neurorehabil Neural Repair. 2021. PMID: 34060934 Free PMC article. Clinical Trial.
We found no interaction between tDCS and MT groups (F = 1.90, P = .13). In the adjusted models, there was a main effect of active tDCS compared to sham tDCS (beta coefficient = -0.99, P = .04) on phantom pain. ...TDCS intervention was associated with increased intra …
We found no interaction between tDCS and MT groups (F = 1.90, P = .13). In the adjusted models, there was a main effect of active tDC …
Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.
Patidar KR, Belcher JM, Regner KR, St Hillien SA, Simonetto DA, Asrani SK, Neyra JA, Sharma P, Velez JCQ, Wadei H, Nadim MK, Chung RT, Seethapathy R, Parada XV, Ouyang T, Ufere NN, Robinson JE, McLean Diaz P, Wilechansky RM, Przybyszewski EM, Smith TN, Ali AA, Orman ES, Schulz P, Siddiqui SM, Shabbir R, Liu LJ, Cama-Olivares A, Flannery AH, Baker ML, Gunasekaran D, Aswine A, Issa R, Li J, Verma S, Chalmers D, Varghese V, Lam W, Mohamed M, Kovacic R, Gaddy A, Attieh RM, Cortes P, Semnani S, Wang L, Khemichian S, Allegretti AS; from the HRS-HARMONY consortium. Patidar KR, et al. Among authors: velez jcq. J Hepatol. 2023 Dec;79(6):1408-1417. doi: 10.1016/j.jhep.2023.07.010. Epub 2023 Jul 28. J Hepatol. 2023. PMID: 37517455
The lowest rate of death was observed in patients with prerenal AKI (22.2%; p <0.001), while death rates were higher but not significantly different from each other in those with HRS-AKI and ATN (49.0% vs. 52.7%; p = 0.42). Using prerenal AKI as a reference, the …
The lowest rate of death was observed in patients with prerenal AKI (22.2%; p <0.001), while death rates were higher but not signi …
Early Biomarker Signatures in Surgical Sepsis.
Madushani RWMA, Patel V, Loftus T, Ren Y, Li HJ, Velez L, Wu Q, Adhikari L, Efron P, Segal M, Ozrazgat-Baslanti T, Rashidi P, Bihorac A; Sepsis and Critical Illness Research Center Investigators. Madushani RWMA, et al. Among authors: velez l. J Surg Res. 2022 Sep;277:372-383. doi: 10.1016/j.jss.2022.04.052. Epub 2022 May 12. J Surg Res. 2022. PMID: 35569215 Free PMC article.

Cluster I was associated with higher Acute Physiologic Assessment and Chronic Health Evaluation II (30 versus 16, P < 0.001) and SOFA scores (13 versus 5, P < 0.001), greater prevalence of chronic cardiovascular and renal disease (P < 0.001) and sept

…

Cluster I was associated with higher Acute Physiologic Assessment and Chronic Health Evaluation II (30 versus 16, P < 0.001) and S

…
Teprotumumab for Thyroid Eye Disease-related Strabismus.
Dallalzadeh LO, Villatoro GA, Chen L, Sim MS, Movaghar M, Robbins SL, Karlin JN, Khitri MR, Velez FG, Korn BS, Demer JL, Rootman DB, Granet DB, Kikkawa DO. Dallalzadeh LO, et al. Among authors: velez fg. Ophthalmic Plast Reconstr Surg. 2024 Feb 2. doi: 10.1097/IOP.0000000000002611. Online ahead of print. Ophthalmic Plast Reconstr Surg. 2024. PMID: 38319994

After teprotumumab, there was 6 prism diopters (39%) mean reduction in vertical deviation (p < 0.001), without significant change in mean horizontal deviation (p = 0.75). Supraduction, abduction, adduction, and infraduction significantly improved in the more rest

…

After teprotumumab, there was 6 prism diopters (39%) mean reduction in vertical deviation (p < 0.001), without significant change

…
Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?
Velez MA, Garon EB. Velez MA, et al. Clin Cancer Res. 2023 Feb 16;29(4):691-693. doi: 10.1158/1078-0432.CCR-22-3229. Clin Cancer Res. 2023. PMID: 36520037
The accompanying article reports on a study combining the programmed cell death (PD-1) inhibitor nivolumab with the alkylating agent temozolomide in patients with advanced NENs. See related article by Owen et al., p. 731....
The accompanying article reports on a study combining the programmed cell death (PD-1) inhibitor nivolumab with the alkylating agent temozol …
Silyl-Osmium(IV)-Trihydride Complexes Stabilized by a Pincer Ether-Diphosphine: Formation and Reactions with Alkynes.
Babón JC, Esteruelas MA, Oñate E, Paz S, Vélez A. Babón JC, et al. Among authors: velez a. Organometallics. 2022 Jul 18;41(15):2022-2034. doi: 10.1021/acs.organomet.2c00201. eCollection 2022 Aug 8. Organometallics. 2022. PMID: 36866234 Free PMC article.
Complex OsH(4){kappa(3)-P,O,P-[xant(P(i)Pr(2))(2)]} (1) activates the Si-H bond of triethylsilane, triphenylsilane, and 1,1,1,3,5,5,5-heptamethyltrisiloxane to give the silyl-osmium(IV)-trihydride derivatives OsH(3)(SiR(3)){kappa(3)-P,O,P-[xant( …
Complex OsH(4){kappa(3)-P,O,P-[xant(P(i)Pr(2))(2)]} (1) activates the Si-H bond of triethylsilane, triphenylsilane, and …
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.
Velez JCQ, Wong F, Reddy KR, Sanyal AJ, Vargas HE, Curry MP, Gonzalez SA, Pappas SC, Jamil K. Velez JCQ, et al. Kidney360. 2023 Aug 1;4(8):1030-1038. doi: 10.34067/KID.0000000000000132. Epub 2023 May 5. Kidney360. 2023. PMID: 37143199 Free PMC article.
More patients were alive and RRT-free by day 90 in the overall population (36.9% versus 28.5%; P = 0.030) and among patients who received an LT (60.0% versus 39.7%; P = 0.010). Random assignment to receive terlipressin was an independent positive predictor of avoida …
More patients were alive and RRT-free by day 90 in the overall population (36.9% versus 28.5%; P = 0.030) and among patients who rece …
Repercussion of a 1,3-Hydrogen Shift in a Hydride-Osmium-Allenylidene Complex.
Esteruelas MA, Oñate E, Paz S, Vélez A. Esteruelas MA, et al. Among authors: velez a. Organometallics. 2021 May 24;40(10):1523-1537. doi: 10.1021/acs.organomet.1c00176. Epub 2021 May 12. Organometallics. 2021. PMID: 35693112 Free PMC article.
The hydride-osmium(II)-allenylidene complex was prepared in two steps, starting from the tetrahydride dimer [(Os(H...H){kappa(3)-P,O,P-[xant(P (i) Pr(2))(2)]})(2)(mu-Cl)(2)][BF(4)](2) (1). Complex 1 reacts with 1,1-diphenyl-2-propyn-1-ol to give the hydride-o …
The hydride-osmium(II)-allenylidene complex was prepared in two steps, starting from the tetrahydride dimer [(Os(H...H){kappa(3)-P,O, …
881 results